Results 181 to 190 of about 5,773 (216)
Some of the next articles are maybe not open access.

Antithyroid Effect of Chlorpropamide?

Human Toxicology, 1983
1 The relationship between plasma chlorpropamide concentration and thyroid function was examined in 87 maturity onset diabetic patients receiving chronic therapy. 2 Although plasma chlorpropamide concentration was weakly negatively correlated with serum thyroxine (r= 0.33, P< 0.01) the mean serum thyroxine and thyrotrophin (TSH) were not different
S. McLaren   +6 more
openaire   +3 more sources

Chlorpropamide metabolism

open access: bronzeThe American Journal of Medicine, 1981
Thomas G. Skillman
openaire   +4 more sources

Plasma chlorpropamide: A critical factor in chlorpropamide-alcohol flush

European Journal of Clinical Pharmacology, 1983
The chlorpropamide-alcohol flush (CPAF) phenomenon was quantitatively related to blood levels of acetaldehyde and chlorpropamide in 105 Type II diabetics, of whom 74 had not previously taken the drug and 31 were on chronic treatment. Standardized skin temperature recordings were made with a sensitive probe.
Hans Öhlin   +4 more
openaire   +3 more sources

Chlorpropamide and Angina Pectoris

Annals of Internal Medicine, 1973
Excerpt To the editor: Chlorpropamide is useful in diabetes insipidus for reduction of free water clearance (1), but there have also been reports of water intoxication and low-sodium syndromes with...
openaire   +3 more sources

Chlorpropamide-Induced Agranulocytosis

JAMA: The Journal of the American Medical Association, 1977
AGRANULOCYTOSIS is a rare complication of chlorpropamide (Diabinese) therapy; it usually subsides as the drug is withdrawn. Death from this form of agranulocytosis is rare, with overwhelming infection the usual cause. 1-3 We report a case of spontaneously remitting agranulocytosis.
Stanley C. Tucker   +2 more
openaire   +3 more sources

Interaction of Rifampin and Chlorpropamide

Chest, 1980
A 62-year-old man who had been taking 250 mg of chlorpropamide daily for several years received rifampin concomitantly and had a subsequent increased dosing requirement of chlorpropamide. When rifampin was discontinued several months later, the serum chlorpropamide concentration rose dramatically.
Timothy H. Self, Tandy Morris
openaire   +3 more sources

Chlorpropamide in the Management of Diabetes

Archives of Internal Medicine, 1959
Chlorpropamide is a new oral antidiabetic agent. Its chemical name isN-propyl-N'-(p-chloro-benzenesulfonyl)urea. The structural formula (Fig. 1) is similar to other sulfonamide derivatives which have been observed to have a blood-sugar-lowering effect.
Teodora M. Eugenio   +2 more
openaire   +3 more sources

SEVERE CHLORPROPAMIDE TOXICITY

Journal of the American Medical Association, 1960
Chlorpropamide (Diabinese) is a potent, orally used, hypoglycemic sulfonylurea derivative that recently has been used in the management of diabetes mellitus. Earlier reports 1 of clinical trials have, in general, mentioned only minimal sideeffects or none at all when the drug is used in recommended therapeutic doses.
Edwin L. Rothfeld   +3 more
openaire   +3 more sources

CHLORPROPAMIDE‐INDUCED HYPONATRAEMIA

Medical Journal of Australia, 1975
A case of hyponatraemia occurring in a 69-year-old diabetic woman taking chlorpropamide is reported. Increasing the dose of chlorpropamide aggravated the hyponatraemia, and the condition corrected itself when the chlorpropamide was withdrawn. It is believed, therefore, that, in the absence of any other cause for the hyponatraemia, chlorpropamide was ...
Arthur Horniblow, Howard J. Peak
openaire   +3 more sources

Metabolism of Chlorpropamide [PDF]

open access: possibleDiabetes Care, 1981
Campbell Rk, Hansten Pd
openaire   +2 more sources

Home - About - Disclaimer - Privacy